Influenza Virus B/Austria/1359417/2021 - Like Strain (B/Austria/1359417/2021, Medi 355292), Influenza Virus A/Victoria/4897/2022 (H1N1)Pdm09 - Like Strain (A/Norway/31694/2022, Medi 369815), Influenza Virus A/Thailand/8/2022 (H3N2)-Like Strain (A/Thailand/8/2022, Medi 370626)

2 trials JAnti-infectives

Filter these 2 trials by condition, phase, country and more.

Open in Search →

2 Registered trials

0 Recruiting

2 Completed trials

2 Sponsors

2 Countries

Phase IV

Phase IV: 2

Sponsors using this IMP

Gentofte Hospital 1 Leids Universitair Medisch Centrum (LUMC) 1

All trials

2 total

Studying the LAIV induced Immune respOnse in the Nasopharynx of young children. Ended

2024-513933-18-00 Phase IV 1 country Leids Universitair Medisch Centrum (LUMC)
VAXXAIR TRIAL: In-depth Immunological Analysis of Airway Immunity following Nasal Live Attenuated and Intramuscular Influenza Vaccine A ran… Ended

2023-506166-31-01 Phase IV 1 country Gentofte Hospital

Showing 1–2 of 2 trials

← All drugs A–Z